FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharmaceutical Industries Metformin Hydrochloride Extended Release Recall

Metformin Hydrochloride Extended Release Tablets, USP, 500 mg, packaged in a 500-count…

Sun Pharmaceutical Industries, Inc. · Cranbury, NJ

Risk level
Class II
Reported by FDA
Jul 25, 2018
Recall ID
D-0924-2018
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Metformin Hydrochloride Extended Release starting Jul 3, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0924-2018 on Jul 25, 2018. Reason: Presence of foreign substance: One lot fo Metformin Hydrochloride Extended Release Tablets, USP, 500 mg (500 Count) contains foreign matter identified as a piece of rubber glove detected in one tablet. Status: Terminated.

Why it was recalled

Presence of foreign substance: One lot fo Metformin Hydrochloride Extended Release Tablets, USP, 500 mg (500 Count) contains foreign matter identified as a piece of rubber glove detected in one tablet.

Product description

Metformin Hydrochloride Extended Release Tablets, USP, 500 mg, packaged in a 500-count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350 Gujarat. India, NDC 62756-142-02

Lot numbers, UPCs & expiration codes

Lot #: JKT0042A, Exp 1/2021

Where it was sold

AZ

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0924-2018
Classification
Class II
Status
Terminated
Recall initiated
Jul 3, 2018
FDA report date
Jul 25, 2018
Quantity
2508 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharmaceutical Industries, Inc.

Original FDA data

Every field from FDA enforcement report D-0924-2018, exactly as published.

Show all FDA fields
City
Cranbury
State
NJ
Status
Terminated
Country
United States
Event ID
80440
Address
270 Prospect Plains Rd
Code information
Lot #: JKT0042A, Exp 1/2021
Postal code
08512-3605
Report date
Jul 25, 2018
Product type
Drugs
Recall number
D-0924-2018
Classification
Class II
Recalling firm
Sun Pharmaceutical Industries, Inc.
Product quantity
2508 bottles
Termination date
Nov 5, 2019
Reason for recall
Presence of foreign substance: One lot fo Metformin Hydrochloride Extended Release Tablets, USP, 500 mg (500 Count) contains foreign matter identified as a piece of rubber glove detected in one tablet.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metformin Hydrochloride Extended Release Tablets, USP, 500 mg, packaged in a 500-count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350 Gujarat. India, NDC 62756-142-02
Distribution pattern
AZ
Recall initiation date
Jul 3, 2018
Initial firm notification
Letter
Center classification date
Jul 13, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0924-2018, published Jul 25, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls